AIRR - ANZCA Institutional Research Repository
Skip navigation
Please use this identifier to cite or link to this item: http://hdl.handle.net/11055/855
Title: Association of Unrecognized Obstructive Sleep Apnea With Postoperative Cardiovascular Events in Patients Undergoing Major Noncardiac Surgery
Authors: Chan MTV,
Wang CY,
Seet E,
Tam S,
Lai HY,
Chew EFF,
Wu WKK,
Cheng BCP,
Lam CKM,
Short TG,
Hui DSC,
Chung F,
Postoperative Vascular Complications in Unrecognized Obstructive Sleep Apnea (POSA) Study Investigators
ANZCA/FPM Author: ANZCA Clinical Trials Network
Chan, MTV
Short, TG
Issue Date: 14-May-2019
Citation: JAMA. 2019 May 14;321(18):1788-1798
Abstract: IMPORTANCE: Unrecognized obstructive sleep apnea increases cardiovascular risks in the general population, but whether obstructive sleep apnea poses a similar risk in the perioperative period remains uncertain. OBJECTIVES: To determine the association between obstructive sleep apnea and 30-day risk of cardiovascular complications after major noncardiac surgery. DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort study involving adult at-risk patients without prior diagnosis of sleep apnea and undergoing major noncardiac surgery from 8 hospitals in 5 countries between January 2012 and July 2017, with follow-up until August 2017. Postoperative monitoring included nocturnal pulse oximetry and measurement of cardiac troponin concentrations. EXPOSURES: Obstructive sleep apnea was classified as mild (respiratory event index [REI] 5-14.9 events/h), moderate (REI 15-30), and severe (REI >30), based on preoperative portable sleep monitoring. MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of myocardial injury, cardiac death, heart failure, thromboembolism, atrial fibrillation, and stroke within 30 days of surgery. Proportional-hazards analysis was used to determine the association between obstructive sleep apnea and postoperative cardiovascular complications. RESULTS: Among a total of 1364 patients recruited for the study, 1218 patients (mean age, 67 [SD, 9] years; 40.2% women) were included in the analyses. At 30 days after surgery, rates of the primary outcome were 30.1% (41/136) for patients with severe OSA, 22.1% (52/235) for patients with moderate OSA, 19.0% (86/452) for patients with mild OSA, and 14.2% (56/395) for patients with no OSA. OSA was associated with higher risk for the primary outcome (adjusted hazard ratio [HR], 1.49 [95% CI, 1.19-2.01]; P = .01); however, the association was significant only among patients with severe OSA (adjusted HR, 2.23 [95% CI, 1.49-3.34]; P = .001) and not among those with moderate OSA (adjusted HR, 1.47 [95% CI, 0.98-2.09]; P = .07) or mild OSA (adjusted HR, 1.36 [95% CI, 0.97-1.91]; P = .08) (P = .01 for interaction). The mean cumulative duration of oxyhemoglobin desaturation less than 80% during the first 3 postoperative nights in patients with cardiovascular complications (23.1 [95% CI, 15.5-27.7] minutes) was longer than in those without (10.2 [95% CI, 7.8-10.9] minutes) (P < .001). No significant interaction effects on perioperative outcomes were observed with type of anesthesia, use of postoperative opioids, and supplemental oxygen therapy. CONCLUSIONS AND RELEVANCE: Among at-risk adults undergoing major noncardiac surgery, unrecognized severe obstructive sleep apnea was significantly associated with increased risk of 30-day postoperative cardiovascular complications. Further research would be needed to assess whether interventions can modify this risk.
URI: http://hdl.handle.net/11055/855
DOI: 10.1001/jama.2019.4783
PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/?term=Association+of+Unrecognized+Obstructive+Sleep+Apnea+With+Postoperative+Cardiovascular+Events+in+Patients+Undergoing+Major+Noncardiac+Surgery
Journal Title: JAMA
Type: Journal Article
Affiliates: Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
University of Malaya, Kuala Lumpur, Malaysia
Khoo Teck Puat Hospital, Singapore
Scarborough Health Network, Ontario, Canada
Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.
Tuen Mun Hospital, Hong Kong Special Administrative Region, China.
Auckland City Hospital, Auckland, New Zealand.
Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada
Study/Trial: Clinical Trial
Appears in Collections:Scholarly and Clinical

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.